NEU 6.41% $15.27 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1305

  1. 501 Posts.
    lightbulb Created with Sketch. 287
    Hi hottod, thanks as always for your insights. Is it me or does Steve Davis seem to trip over his tongue a lot more these days when he presents/answers questions?

    I’m not trying to be superficial or disrespectful, but I’ve been listening to him for 18 months now and I feel like his answers and general oration is much less self-assured these days. I can’t work out if he’s lost his confidence, is personally under pressure due to the depressed ACAD share price and/or guidance misses or if he’s dissembling and desperately trying not to reveal anything that he shouldn’t.

    Has anyone else noticed this or am I going mad and looking for anything to focus on apart on from our pitiful share price?

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.